Respiratory Mechanics in Lung Disease and Surgery
肺部疾病和外科手术中的呼吸力学
基本信息
- 批准号:6537132
- 负责人:
- 金额:$ 27.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-01 至 2005-06-30
- 项目状态:已结题
- 来源:
- 关键词:biomechanics chronic obstructive pulmonary disease computed axial tomography homologous transplantation human subject human therapy evaluation lung lung transplantation muscle function patient oriented research plethysmography postoperative state preoperative state pulmonary respiration respiratory airway volume respiratory function respiratory muscles respiratory surgery thorax
项目摘要
DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease
(COPD) is a life-threatening, debilitating disease affecting more than 2
million Americans. New surgical therapies such as lung transplantation and lung
volume reduction surgery (LVRS) can improve quality of life and pulmonary
function in COPD. However, questions remain as to which patients are most
likely to benefit from these therapies and why surgery is effective in some
patients and not in others. We will continue an observational study of
respiratory mechanics in a large cohort of patients with COPD before and after
lung transplantation and LVRS. Our rationale is that our coordinated program of
respiratory mechanical investigation will continue to provide insights and
suggest useful measures of respiratory function that will reveal mechanisms of
disease. Specific aims are: 1) To measure the maximal inspiratory
pressure-volume characteristic of the chest wall in patients before and after
lung transplantation or LVRS to assess changes in inspiratory function of the
chest wall. We will test the hypothesis that inspiratory function of the chest
wall is often compromised after operation, and that chest wall restriction is
an important cause of failure to improve after LVRS or single lung
transplantation for emphysema. If true, this finding would lead to studies of
the origins and remedies of chest wall restriction after surgery. 2) To explore
the differences between lung volumes measured by multiple breath helium
dilution, plethysmography, and computed tomography (CT). Accurate measurements
of lung volume are essential for diagnosis, for documentation of
hyperinflation, for evaluation of patients before surgery, and for assessment
of the effects of LVRS and transplantation. We will test the hypothesis that,
contrary to current belief, helium dilution is more accurate than
plethysmography in patients with COPD. If true, this finding would change
clinical practice in this important group. 3) To develop methods to measure the
pressure-area characteristics of the trachea in patients undergoing
bronchoscopy and to determine whether the site of expiratory flow limitation in
these patients is in the lungs or trachea. Acquired tracheomalacia is
reportedly common in patients with COPD, and can cause severe expiratory
obstruction that may be relieved by stenting or surgical reinforcement of the
airway. We will test the hypothesis that many patients with demonstrated
tracheomalacia and central airway collapse have obstruction caused by collapse
of intrapulmonary airways, which is not amenable to surgical correction. Our
findings will provide normative data on tracheal collapsibility not currently
available, explore the association between tracheomalacia and COPD, and test a
method for predicting the effect of stenting on expiratory obstruction in these
patients.
描述(由申请人提供):慢性阻塞性肺疾病
慢性阻塞性肺疾病(COPD)是一种危及生命、使人衰弱的疾病,
百万美国人。新的外科治疗,如肺移植和肺
减容手术(LVRS)可以改善患者的生活质量和肺功能,
在COPD中的作用然而,问题仍然存在,哪些患者最
可能从这些治疗中受益,以及为什么手术在一些
病人,而不是其他人。我们将继续进行观察性研究,
一个大型队列COPD患者治疗前后的呼吸力学
肺移植和LVRS。我们的理由是,我们的协调计划,
呼吸机械研究将继续提供见解,
提出了有用的呼吸功能测量方法,将揭示
疾病具体目的是:1)测量最大吸气量
胸壁压力-容积特性
肺移植或LVRS,以评估患者吸气功能的变化。
胸壁侧我们将检验胸腔的吸气功能
手术后胸壁经常受到损害,胸壁限制是
LVRS或单肺切除术后未能改善的重要原因
移植治疗肺气肿如果这是真的,这一发现将导致对
术后胸壁受限的原因及治疗。2)探讨
多次呼吸氦气测量的肺容量之间的差异
稀释、体积描记和计算机断层扫描(CT)。精确的测量
肺容量的变化对于诊断、记录
过度充气,用于术前患者评价和评估
LVRS和移植的效果。我们将检验这个假设,
与目前的看法相反,氦稀释比
COPD患者的体积描记法。如果这是真的,
在这个重要的群体中的临床实践。3)制定方法来衡量
气管插管患者的气管压力-面积特征
支气管镜检查,并确定是否呼气流量限制的网站,
这些病人是在肺部或气管。获得性气管软化症是
据报道,COPD患者中常见,
可以通过支架植入术或手术加固
气道。我们将检验一个假设,即许多患有
气管软化和中央气道塌陷有塌陷引起的阻塞
肺内气道,这是不适合手术纠正。我们
研究结果将提供目前尚未提供的关于气管可扩张性的规范性数据
现有资料,探索气管软化症和COPD之间的关系,并测试a
用于预测支架植入术对这些患者呼气阻塞的影响的方法
患者
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN H LORING其他文献
STEPHEN H LORING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN H LORING', 18)}}的其他基金
EPVent 2-A Phase II Trial Esophageal Pressure Guided Ventilation
EPVent 2-A II 期试验食管压力引导通气
- 批准号:
8700476 - 财政年份:2012
- 资助金额:
$ 27.79万 - 项目类别:
EPVent 2-A Phase II Trial Esophageal Pressure Guided Ventilation
EPVent 2-A II 期试验食管压力引导通气
- 批准号:
8536932 - 财政年份:2012
- 资助金额:
$ 27.79万 - 项目类别:
EPVent 2-A Phase II Trial Esophageal Pressure Guided Ventilation
EPVent 2-A II 期试验食管压力引导通气
- 批准号:
8283454 - 财政年份:2012
- 资助金额:
$ 27.79万 - 项目类别:
相似海外基金
ARE COMMONLY USED CARDIOVASCULAR RISK SCORING TOOLS RELIABLE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)?
常用的心血管风险评分工具对于慢性阻塞性肺疾病 (COPD) 患者可靠吗?
- 批准号:
493118 - 财政年份:2023
- 资助金额:
$ 27.79万 - 项目类别:
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
解读芳烃受体 (AhR) 如何控制香烟烟雾引起的肺部炎症和慢性阻塞性肺病 (COPD) 的发展
- 批准号:
487508 - 财政年份:2023
- 资助金额:
$ 27.79万 - 项目类别:
Operating Grants
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
- 批准号:
10633608 - 财政年份:2023
- 资助金额:
$ 27.79万 - 项目类别:
Optimisation of precision therapy for chronic obstructive pulmonary disease: A dynamic treatment regime analysis
慢性阻塞性肺疾病精准治疗优化:动态治疗方案分析
- 批准号:
489950 - 财政年份:2023
- 资助金额:
$ 27.79万 - 项目类别:
Operating Grants
Elucidation of the mechanism of sarcopenia associated with chronic obstructive pulmonary disease
阐明肌肉减少症与慢性阻塞性肺疾病相关的机制
- 批准号:
23K15702 - 财政年份:2023
- 资助金额:
$ 27.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Risk factors for chronic obstructive pulmonary disease exacerbations, quality of care, and outcomes in people with HIV
HIV 感染者慢性阻塞性肺病恶化的危险因素、护理质量和结果
- 批准号:
10700228 - 财政年份:2023
- 资助金额:
$ 27.79万 - 项目类别:
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease
肺炎球菌抗体功能受损和慢性阻塞性肺疾病恶化
- 批准号:
10543560 - 财政年份:2022
- 资助金额:
$ 27.79万 - 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测
- 批准号:
10445739 - 财政年份:2022
- 资助金额:
$ 27.79万 - 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_Supplement
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测_补充
- 批准号:
10772527 - 财政年份:2022
- 资助金额:
$ 27.79万 - 项目类别:
Pulmonary Vascular Disease as a Contributor to Respiratory Morbidity in Chronic Obstructive Pulmonary Disease
肺血管疾病是慢性阻塞性肺疾病呼吸系统疾病发病的一个原因
- 批准号:
10449417 - 财政年份:2022
- 资助金额:
$ 27.79万 - 项目类别: